Compound Information | |
---|---|
ID | 217 |
TrivialName | 24(R)-Pseudoginsenoside F11 |
Type | OT |
MF | C₄₂H₇₂O₁₄ |
MolecularWeight | 801.024000000001 |
IUPACName | (2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol |
m/z | 845.4891 |
Retention Time | 17.59 |
CCS | 300.84 |
Adducts | [M−H+HCOOH]− |
Isomeric SMILES | O[C@H]1CC[C@@]2(C)[C@]([C@@H](O[C@H]3[C@H](O[C@H]4[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O4)[C@@H](O)[C@H](O)[C@@H](CO)O3)C[C@]5(C)C2C[C@@H](O)C6[C@@]5(C)CCC6[C@@]7(C)CCC(C(C)(O)C)O7)([H])C1(C)C |
Canonical SMILES | CC1OC(OC2C(OC3CC4(C)C(CC(O)C5C(C6(C)CCC(C(C)(C)O)O6)CCC54C)C4(C)CCC(O)C(C)(C)C34)OC(CO)C(O)C2O)C(O)C(O)C1O |
Source | PpGh |
Functions | effective on central nervous system disorders |
Year | 1978 |
References | |
Structure |
|